Pratter, who oversaw the GLP-1 RA litigation, passed away at 78
Weight, glucose parameters, and adverse effect assessment inform protocol adjustments
Making a Transition Transitioning from a compounded to an FDA-approved GLP-1 medication should be done under the guidance of a health care professional, Alyssa Billingsley, PharmD, director of pharmacy content at GoodRx, said, noting that such an individual can help the patient navigate any changes to the formulation, concentration, dosage, or delivery method
Semaglutide is a synthetic GLP-1 receptor agonist peptide widely utilized in laboratory research involving metabolic pathways, peptide pharmacology, receptor biology, and endocrine regulation
Laboratory verification THIRD-PARTY TESTED Independently analysed Every peptide is screened by an accredited independent laboratory
Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression